These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33382567)

  • 1. Medications for Treatment-Resistant Depression in Adults.
    Arnold MJ; Fulleborn S; Farrell J
    Am Fam Physician; 2021 Jan; 103(1):16-18. PubMed ID: 33382567
    [No Abstract]   [Full Text] [Related]  

  • 2. Choosing medications for treatment-resistant depression based on mechanism of action.
    Thase ME; Schwartz TL
    J Clin Psychiatry; 2015 Jun; 76(6):720-7; quiz 727. PubMed ID: 26132673
    [No Abstract]   [Full Text] [Related]  

  • 3. Esketamine for treatment resistant depression: a trick of smoke and mirrors?
    Gastaldon C; Papola D; Ostuzzi G; Barbui C
    Epidemiol Psychiatr Sci; 2019 Dec; 29():e79. PubMed ID: 31841104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using mechanism of action to choose medications for treatment-resistant depression.
    Thase ME; Schwartz TL
    J Clin Psychiatry; 2015 Sep; 76(9):e1147. PubMed ID: 26455685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole Augmentation in Older Persons with Treatment-Resistant Depression.
    Lewis G; Lewis G
    N Engl J Med; 2023 Mar; 388(12):1137-1138. PubMed ID: 36867178
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.
    Frye MA; Blier P; Tye SJ
    J Clin Psychopharmacol; 2015 Jun; 35(3):334-6. PubMed ID: 25928701
    [No Abstract]   [Full Text] [Related]  

  • 7. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.
    Singh I; Morgan C; Curran V; Nutt D; Schlag A; McShane R
    Lancet Psychiatry; 2017 May; 4(5):419-426. PubMed ID: 28395988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-resistant depression: A plea to mull over!
    Naguy A; Alamiri B; Al Awadhi DS
    Asian J Psychiatr; 2018 Aug; 36():69-70. PubMed ID: 29979996
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 10. New medications for treatment-resistant depression: a brief review of recent developments.
    Thase ME
    CNS Spectr; 2017 Dec; 22(S1):39-48. PubMed ID: 29350129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine: Future Treatment For Unresponsive Depression?
    Frere M; Tepper J
    Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive medication strategies for treatment-resistant depression.
    Lam RW
    Can J Psychiatry; 2011 Jun; 56(6):315-6. PubMed ID: 21756444
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment-resistant depression: a challenge for future research.
    Kasper S
    Acta Neuropsychiatr; 2014 Jun; 26(3):131-3. PubMed ID: 25279416
    [No Abstract]   [Full Text] [Related]  

  • 14. Esketamine (Spravato) for Treatment-Resistant Depression.
    Jalloh M
    Am Fam Physician; 2020 Mar; 101(6):339-340. PubMed ID: 32163257
    [No Abstract]   [Full Text] [Related]  

  • 15. Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.
    Escalona R; Fawcett J
    Neuropsychopharmacology; 2017 Jan; 42(1):363. PubMed ID: 27909317
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
    Torjesen I
    BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
    [No Abstract]   [Full Text] [Related]  

  • 17. Esketamine as a treatment for paediatric depression: questions of safety and efficacy.
    Zimmermann KS; Richardson R; Baker KD
    Lancet Psychiatry; 2020 Oct; 7(10):827-829. PubMed ID: 31952957
    [No Abstract]   [Full Text] [Related]  

  • 18. [MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].
    Köhler S; Stöver LA; Bschor T
    Fortschr Neurol Psychiatr; 2014 Apr; 82(4):228-36; quiz 237-8. PubMed ID: 24710679
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment-resistant depression: problematic illness or a problem in our approach?
    Malhi GS; Das P; Mannie Z; Irwin L
    Br J Psychiatry; 2019 Jan; 214(1):1-3. PubMed ID: 30565539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression - Advanced Treatments for Treatment-Resistant Depression.
    Cristancho M; Fava M; Ingelfinger J; Nikayin S; Sanacora G
    N Engl J Med; 2024 May; 390(20):e44. PubMed ID: 38810184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.